Novelion Therapeutics Inc's ROI from its first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Novelion Therapeutics Inc's ROI in the first quarter of 2019?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Novelion Therapeutics Inc 's return on investment (ROI) in its first quarter of 2019

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter	(Mar 31 2018) I. Quarter
Y / Y Investment Change TTM	-	-70.45 %	-44.99 %	5 %	65.48 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-117	-88	-69	249	271
Return On Investment (TTM)	-	-	-	-51.09 %	-44.22 %
NVLN's Overall Ranking	# 4496	# 0	# 0	# 0	# 0
Seq. Investment Change TTM	-	-49.86 %	-32.96 %	-6.84 %	-5.64 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-107	-108	-113	-138	-129

NVLN Company Profile >> Back to NVLN Roi Comparisons >> See Annual NVLN Return On Investment

Return On Investment NVLN's Ranking
Within:	No.
Industry	# 378
Sector	# 753
Overall	# 4496

Return On Investment Statistics
High	Average	Low
-12.31 %	-145.09 %	-721.14 %
(Dec 31 2017)		(Mar 31 2019)

Financial Statements
Novelion Therapeutics Inc's I. Quarter Investments	$ -117 Millions	NVLN's Balance sheet
Novelion Therapeutics Inc's I. Quarter Income	$ -32 Millions	Quarterly NVLN's Income Statement
NVLN's Income by Division		See NVLN's Income by Division

NVLN Annual Return On Investment	(Dec 31 2018) 2018	(Dec 31 2017) 2017	(Dec 31 2016) 2016
Total Investments in Millions	-88	274	362	0	0
Y / Y Investment Growth	-	-24.29 %	-	-	-
Net Income in Millions	-108	-127	-53	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-46.23 %	-14.61 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NVLN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NVLN's Competitors
Subscribers only: Roi for Novelion Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for NVLN's Customers

Other Ratios
NVLN's Roa	NVLN's Inventory Turnover Ratio	NVLN's Growth Rates	NVLN's Dividend Statistics
	NVLN's Profitability Ratios	NVLN's Asset Turnover Ratio	NVLN's Dividend Growth
NVLN's Roe	NVLN's Valuation Ratios	NVLN's Financial Strength Ratios	NVLN's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2019, within Healthcare Sector	ROI
Zomedica Corp	1,110.36 %
Siga Technologies Inc	639.65 %
Tuhura Biosciences Inc	427.91 %

Date modified: 2026-09-08T15:09:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.